Mariam Gachechiladze

685 total citations
30 papers, 486 citations indexed

About

Mariam Gachechiladze is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mariam Gachechiladze has authored 30 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mariam Gachechiladze's work include Cervical Cancer and HPV Research (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Ubiquitin and proteasome pathways (3 papers). Mariam Gachechiladze is often cited by papers focused on Cervical Cancer and HPV Research (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Ubiquitin and proteasome pathways (3 papers). Mariam Gachechiladze collaborates with scholars based in Czechia, Switzerland and Georgia. Mariam Gachechiladze's co-authors include Jozef Škarda, Gvantsa Kharaishvili, Jan Bouchal, Kateřina Bouchalová, Markus Joerger, Dana Šimková, Alex Soltermann, Zdeněk Tauber, Kateřina Čížková and Martin Mistrík and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Mariam Gachechiladze

25 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariam Gachechiladze Czechia 11 255 207 81 81 67 30 486
Yoshinari Shinsato Japan 14 284 1.1× 164 0.8× 72 0.9× 129 1.6× 110 1.6× 20 523
Margarite D. Matossian United States 14 314 1.2× 258 1.2× 50 0.6× 136 1.7× 42 0.6× 39 588
Patrycja Pawlikowska France 15 391 1.5× 177 0.9× 59 0.7× 137 1.7× 53 0.8× 24 682
Alison G. Barber United States 6 413 1.6× 256 1.2× 68 0.8× 170 2.1× 79 1.2× 8 639
Chongkui Sun China 13 337 1.3× 192 0.9× 62 0.8× 124 1.5× 31 0.5× 16 621
Arulselvi Anbalagan United States 8 222 0.9× 203 1.0× 61 0.8× 175 2.2× 74 1.1× 10 486
Patrick Grierson United States 14 271 1.1× 206 1.0× 44 0.5× 85 1.0× 32 0.5× 38 514
Abhishek S. Kashyap Switzerland 9 186 0.7× 225 1.1× 74 0.9× 80 1.0× 46 0.7× 14 489
Wasfi Alrawashdeh United Kingdom 7 203 0.8× 257 1.2× 68 0.8× 164 2.0× 60 0.9× 13 514
Stefano Marastoni Italy 9 302 1.2× 110 0.5× 48 0.6× 113 1.4× 78 1.2× 14 522

Countries citing papers authored by Mariam Gachechiladze

Since Specialization
Citations

This map shows the geographic impact of Mariam Gachechiladze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariam Gachechiladze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariam Gachechiladze more than expected).

Fields of papers citing papers by Mariam Gachechiladze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariam Gachechiladze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariam Gachechiladze. The network helps show where Mariam Gachechiladze may publish in the future.

Co-authorship network of co-authors of Mariam Gachechiladze

This figure shows the co-authorship network connecting the top 25 collaborators of Mariam Gachechiladze. A scholar is included among the top collaborators of Mariam Gachechiladze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariam Gachechiladze. Mariam Gachechiladze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gachechiladze, Mariam, Sara Nizzero, Sabine Schädelin, et al.. (2024). Abstract 6394: Tissue nanomechanical signature predicts response to neoadjuvant chemotherapy in patients with breast cancer. Cancer Research. 84(6_Supplement). 6394–6394.
2.
Molostvov, Guerman, Mariam Gachechiladze, Abeer M. Shaaban, et al.. (2023). Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner. Cell Reports. 42(3). 112207–112207. 12 indexed citations
4.
Gachechiladze, Mariam, Juanru Guo, Xuhua Chen, et al.. (2023). Calling Cards: A Customizable Platform to Longitudinally Record Protein‐DNA Interactions Over Time in Cells and Tissues. Current Protocols. 3(9). e883–e883. 1 indexed citations
5.
Rigamonti, Nicolò, Niina Veitonmäki, Francesca Malvezzi, et al.. (2022). A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor Regression. Cancer Immunology Research. 10(5). 626–640. 18 indexed citations
8.
Gachechiladze, Mariam, et al.. (2019). MORPHOPHENOTYPIC CHARACTERISTICS OF OVARIAN SEROUS BORDERLINE TUMORS.. PubMed. 20–25. 2 indexed citations
9.
Muzashvili, T, et al.. (2019). TLR9 EXPRESSION, LANGERHANS CELL DENSITY AND LYMPHOCYTIC INFILTRATION IN PROGRESSING CERVICAL INTRAEPITHELIAL NEOPLASIA.. PubMed. 126–130. 2 indexed citations
10.
Gachechiladze, Mariam, et al.. (2019). DISTRIBUTION OF INTRAEPITHELIAL LYMPHOCYTES AND MACROPHAGES IN CERVICAL MICROENVIRONMENT DURING THE PROGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA.. PubMed. 123–128. 1 indexed citations
11.
Gachechiladze, Mariam, J Klein, Gvantsa Kharaishvili, et al.. (2019). Sphingosine kinase‑1 predicts overall survival outcomes in non‑small cell lung cancer patients treated with carboplatin and navelbine. Oncology Letters. 18(2). 1259–1266. 26 indexed citations
12.
Muzashvili, T, et al.. (2019). PHENOTYPIC CHARACTERISTICS OF CHORIONIC VILLI DURING GESTATIONAL TROPHOBLASTIC DISEASES.. PubMed. 140–145.
13.
Majera, Dušana, Zdeněk Škrott, Jan Bouchal, et al.. (2018). Targeting genotoxic and proteotoxic stress‐response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram. The Prostate. 79(4). 352–362. 24 indexed citations
14.
Gachechiladze, Mariam, Jozef Škarda, Vı́tězslav Kolek, et al.. (2017). Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer. 105. 31–38. 7 indexed citations
16.
Kharaishvili, Gvantsa, et al.. (2014). The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell International. 14(1). 41–41. 152 indexed citations
17.
Gachechiladze, Mariam, Jozef Škarda, Maha Ibrahim, et al.. (2014). Primitive neuroectodermal tumor (PNET) of the lung in an adult woman. World Journal of Surgical Oncology. 12(1). 374–374. 10 indexed citations
18.
Škarda, Jozef, Mariam Gachechiladze, Vı́tězslav Kolek, et al.. (2014). The immunohistochemical expression of sphingosine kinase 1 and S1P lyase in non-small cell lung cancer: a tissue microarray study. Pathology. 46. S110–S111. 1 indexed citations
19.
Gachechiladze, Mariam & Jozef Škarda. (2012). The role of BRCA1 in non-small cell lung cancer. Biomedical Papers. 156(3). 200–203. 8 indexed citations
20.
Gachechiladze, Mariam, Vı́tězslav Kolek, J Klein, et al.. (2012). Correlation between BRCA1 expression and clinicopathological factors including brain metastases in patients with non-small-cell lung cancer. Biomedical Papers. 157(3). 227–232. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026